Help us: Donate
Follow us on:
Γ—

Menu

Back

Thyroid Organoids Created From Human Tissue

This innovative approach may one day lead to thyroid replacement.

The thyroid glandThe thyroid gland

In a new study published in Stem Cell Reports, researchers have developed organoids to replace thyroid function [1]. If this approach is fully fleshed out and successfully brought to the clinic, it may become a true cure for hypothyroidism.

A common but harmful affliction

Hypothyroidism is one of the most common afflictions around the world, and its symptoms include depression, anxiety, weight gain, constipation, and fatigue. The current standard of care, a pharmaceutically delivered thyroid hormone known as levothyroxine, does not wholly treat hypothyroidism in 5 to 10 percent of sufferers [2].

As with a great many disorders, hypothyroidism increases with age [3]. In subclinical hypothyroidism, the amount of circulating thyroid-stimulating hormone (TSH) goes up, while the factors produced by the thyroid go down or remain stable; the thyroid requires additional stimulation just to retain its function. This condition is common in older people, as their levels of TSH are, on average, considerably higher than the youthful norm.

Enter the organoid

The current pharmaceutical approach to hypothyroidism is to simply replace at least one of the hormones that the thyroid produces. However, the researchers of this study have created small artificial organs (organoids) that live within tissue and create such hormones themselves. If their approach can go through the development and human clinical trial process, the resulting therapy could potentially function exactly as a human thyroid does, removing the need for pharmaceutically created hormones.

These organoids were not created from specific populations of stem cells. As the researchers explain, they are not yet able to identify, cultivate, and produce individual thyroid stem cells at all. They are also unsure whether or not their culturing medium causes differentiated thyroid cells to revert to a stem cell state; which would represent the same regenerative capacity that liver tissue has. The results of this experiment are shown through aggregation and analysis of the organoids as a whole rather than the specific identification of cells.

Fortunately, these thyroid cells were not shown to generate tumors, which is a frequent problem with regenerative approaches. On the other hand, the amount of actual thyroid hormones generated by these organoids was insufficient to treat hypothyroidism in thyroid-damaged mice. The researchers hypothesize that this was due to the lack of blood vessels connecting to the organoids, and this lack of vascularization is also a commonly known issue with these sorts of regenerative approaches.

The researchers also note that there is a significant discrepancy between murine and human tissue. After one week, less than a sixth of mouse cells remained in proliferative phases of the cellular cycle, while more than a third of human cells stayed in these phases. Such discrepancies between mice and humans are not uncommon in aging research, as our longer lifespans mean that we have regenerative mechanisms that mice lack. In this case, the researchers were able to test human organoids in mice through xenotransplantation.

Abstract

Murine and human thyroid-derived cells were cultured as organoids capable of self-renewal and which expressed proliferation and putative stem cell and thyroid characteristics, without a change in the expression of thyroid tumor-related genes. These organoids formed thyroid-tissue-resembling structures in culture. (Xeno-)transplantation of 600,000 dispersed organoid cells underneath the kidney capsule of a hypothyroid mouse model resulted in the generation of hormone-producing thyroid-resembling follicles. This study provides evidence that thyroid-lineage-specific cells can form organoids that are able to self-renew and differentiate into functional thyroid tissue. Subsequent (xeno-)transplantation of these thyroid organoids demonstrates a proof of principle for functional miniature gland formation.

Conclusion

Tissue engineering of organs such as the thyroid is in its infancy. The researchers present their study as a proof of principle, showing the potential for later human use once this technique is better perfected. If human thyroid organoids make it to the clinic, they may eliminate the need for prescriptions of the thyroid hormone levothyroxine, a compound upon which tens of millions of hypothyroidism sufferers rely.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Linking Bile Duct Blockage and Cellular Senescence

Research published in Aging has shed new light on the relationship between certain liver diseases and cellular senescence. Clogged bile...

Rejuvenation Roundup May 2023

This year, May brought us a shower of research, interviews, and insights into the present and future of rejuvenation biotechnology....

Dietary Magnesium in Dementia Prevention

Researchers publishing in the European Journal of Nutrition looked into magnesium as a possible candidate for preventing dementia, focusing on...

Glycine and Cysteine Combo Rescues Cognitive Decline in Mice

Scientists publishing in Antioxidants have reported that increasing glutathione levels with GlyNAC, a supplement that combines glycine and cysteine, significantly...

Literature

[1] Ogundipe, V. M., Groen, A. H., Hosper, N., Nagle, P. W., Hess, J., Faber, H., … & Coppes, R. P. (2021). Generation and Differentiation of Adult Tissue-Derived Human Thyroid Organoids. Stem Cell Reports.

[2] Wiersinga, W. M. (2014). Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism. Nature Reviews Endocrinology, 10(3), 164.

[3] Calsolaro, V., Niccolai, F., Pasqualetti, G., Tognini, S., Magno, S., Riccioni, T., … & Monzani, F. (2019). Hypothyroidism in the elderly: who should be treated and how?. Journal of the Endocrine Society, 3(1), 146-158.

About the author
Josh Conway

Josh Conway

Josh is a professional editor and is responsible for editing our articles before they become available to the public as well as moderating our Discord server. He is also a programmer, long-time supporter of anti-aging medicine, and avid player of the strange game called β€œreal life.” Living in the center of the northern prairie, Josh enjoys long bike rides before the blizzards hit.
No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.